Use of Zidovudine (Zdv) To Reduce Perinatal Hiv Transmission in Hrsa-Funded Programs (Classic Reprint) - Tapa dura

Sinopsis

Excerpt from Use of Zidovudine (Zdv) To Reduce Perinatal Hiv Transmission in Hrsa-Funded Programs

In February 1994, the National Institutes of Health (nih) announced findings of a study sponsored by the Pediatric aids Clinical Trials Group (actg) which found that a regimen of Zidovudine (zdv) reduced perinatal transmission of hiv by two-thirds in infants whose mothers met specific eligibility criteria. (specifics of the trial and its findings are discussed under actg 076, page These findings have direct implications for the growing number of women with hiv disease, for their children, families, and providers, and for the multiple systems that deliver ongoing services and care.

In response to these findings, agencies of the us. Public Health Service (phs) developed recommendations for providing hiv counseling and voluntary testing to pregnant women1 (see Appendix A) and for offering the zdv perinatal regimen to pregnant women with hiv2 (see Appendix B).

About the Publisher

Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com

This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

"Sinopsis" puede pertenecer a otra edición de este libro.